Related Experiment Video
Updated: Jul 27, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Post nirmatrelvir/ritonavir erythema multiforme in a patient with coronavirus disease infection
José Wagner Leonel Tavares-Júnior1, José Carlos Jucá Pompeu Filho2, Luiz Eduardo Garcia Galvão3
1Universidade Federal do Ceará, Fortaleza, CE, Brasil.
Abstract:
Erythema multiforme (EM), an immune-mediated skin condition, can occur after infection or following the use of medications. In this study, we describe a patient who developed EM after nirmatrelvir/ritonavir administration. An 81-year-old woman presented with fever and dyspnea. Laboratory investigations showed positive coronavirus disease (COVID-19) based on polymerase chain reaction assay, and she received a 5-day regimen of nirmatrelvir/ritonavir. We observed development of EM after this treatment and initiated prednisone (1 mg/kg) therapy, which led to rapid improvement. Our study is the first to report EM in a patient with COVID-19, who received nirmatrelvir/ritonavir and showed a favorable response.
More Related Videos
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
18:46Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
Published on: December 9, 2010
Related Concept Videos
Myocarditis III: Medical Management
Retroviruses
Myocarditis II: Clinical Features and Diagnostic Tests
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Endocarditis II: Clinical Features of Infective Endocarditis
Myocarditis I: Introduction